(Q82180125)

English

MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients

scientific article published on 02 October 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

immunohistochemistry

1 reference

based on heuristic

inferred from title

multiple myeloma

1 reference

based on heuristic

inferred from title

author name string

Ev Stralen

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

R J Leguit

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

H Begthel

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

L Michaux

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

A Buijs

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

H Lemmens

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

J M Scheiff

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

C Doyen

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

P Pierre

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

F Forget

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

H C Clevers

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Bjeg Bast

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

2 October 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

801-803

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830254%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

describes a project that uses

immunohistochemistry

1 reference

based on heuristic

inferred from title

https://scigraph.springernature.com/pub.10.1038/leu.2008.284

0 references

c-Maf nuclear oncoprotein is frequently expressed in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.284

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic events in the pathogenesis of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.284

7 January 2021

based on heuristic

inferred from DOI database lookup

The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.284

7 January 2021

based on heuristic

inferred from DOI database lookup

Wnt signaling controls the phosphorylation status of beta-catenin.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.284

7 January 2021

based on heuristic

inferred from DOI database lookup

MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.284

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.284

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.284

7 January 2021

based on heuristic

inferred from DOI database lookup

C-MAF oncogene dysregulation in multiple myeloma: frequency and biological relevance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.284

7 January 2021

based on heuristic

inferred from DOI database lookup

The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.284

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82180125&oldid=1878964833"